Jarett Worden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jarett Worden has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Tyler Baumeister
Pharmacy, Williamson Medical Center, Franklin, TN 37067, USA
2 shared publications - Ellen F. Eaton
Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
1 shared publication - Jennifer Duck
University of Georgia Grady College of Journalism & Mass Communication, 120 Hooper St, Athens, GA 30602, United States
1 shared publication - Nancy Henin
Williamson Medical Center, 4321 Carothers Parkway, Franklin, TN 37067
1 shared publication - Rebecca A. Stern
Vanderbilt University Medical Center
1 shared publication - Sarah Stogner
Pharmacy Student, Class of 2026, Belmont University College of Pharmacy & Health Sciences, 1900 Belmont Blvd, Nashville, TN 37212
1 shared publication
Latest Publications
- Open Access
- 9 September 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (9) , 881
Optimizing Treatment of Infective Endocarditis in Patients Who Inject Drugs
The treatment of infective endocarditis (IE) in patients who inject drugs (PWID) is complex and challenging. These patients face stigma in the healthcare system, as well as higher mortality, longer length of hospital stay, higher rates of recurrent infections, and lower likelihood of antibiotic completion. Standard treatment for IE involves several weeks of antibiotics. For PWID, these prolonged courses often mean intravenous antibiotics administered in the inpatient setting for at least 4 to 6 weeks, which increases both healthcare costs and the risk of patient-directed discharge against medical advice. Effective treatment of IE in PWID involves a combination of addiction management and appropriate antibiotic therapy. To promote rational use of healthcare resources and optimize antibiotic stewardship, novel approaches to antibiotic therapy must be utilized. This review discusses evidence supporting treatment strategies outside of the inpatient hospital setting, including outpatient parenteral antibiotic therapy (OPAT), long-acting lipoglycopeptides, and oral antibiotic therapy for the treatment of endocarditis. Optimal treatment of IE in PWID involves support from a multidisciplinary healthcare team, management of substance use disorder, and effective antibiotic therapy.
- 9 September 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (9) , 881
Open AccessOptimizing Treatment of Infective Endocarditis in Patients Who Inject Drugs
The treatment of infective endocarditis (IE) in patients who inject drugs (PWID) is complex and challenging. These patients face stigma in the healthcare system, as well as higher mortality, longer length of hospital stay, higher rates of recurrent infections, and lower likelihood of antibiotic completion. Standard treatment for IE involves several weeks of antibiotics. For PWID, these prolonged courses often mean intravenous antibiotics administered in the inpatient setting for at least 4 to 6 weeks, which increases both healthcare costs and the risk of patient-directed discharge against medical advice. Effective treatment of IE in PWID involves a combination of addiction management and appropriate antibiotic therapy. To promote rational use of healthcare resources and optimize antibiotic stewardship, novel approaches to antibiotic therapy must be utilized. This review discusses evidence supporting treatment strategies outside of the inpatient hospital setting, including outpatient parenteral antibiotic therapy (OPAT), long-acting lipoglycopeptides, and oral antibiotic therapy for the treatment of endocarditis. Optimal treatment of IE in PWID involves support from a multidisciplinary healthcare team, management of substance use disorder, and effective antibiotic therapy.
- 19 December 2025
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (2) , 103009
Methemoglobinemia induced by dapsone, hydroxychloroquine, and rifampin combination for post-treatment Lyme disease syndrome: A case report
- 19 December 2025
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (2) , 103009
Methemoglobinemia induced by dapsone, hydroxychloroquine, and rifampin combination for post-treatment Lyme disease syndrome: A case report
- Open Access
- 7 October 2025
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 18 (1) , 102506
From proposal to podcast: Starting a student-driven pharmacy podcast in the classroom
- 7 October 2025
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 18 (1) , 102506
Open AccessFrom proposal to podcast: Starting a student-driven pharmacy podcast in the classroom
- Open Access
- 27 March 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (4) , ofaf150
Trends in the Management of Infective Endocarditis for Patients Who Inject Drugs: A Survey of Healthcare Facilities in Tennessee
Background: The current endocarditis management strategies among Tennessee healthcare facilities for people who inject drugs (PWID) were evaluated. Methods: This was a survey-based study of healthcare facilities that treat infective endocarditis in PWID within Tennessee. The primary outcome of the study was to describe current practice among facilities regarding the treatment of endocarditis in PWID, including approaches to addiction management, antimicrobial therapy, and cardiac surgery. Results: There were 17 facilities that responded to the survey but only 16 facilities completed the entire survey. Although 15 facilities (88%) responded that they evaluate patients for substance use disorders on admission, only 4 (24%) of those facilities offered addiction consultation service. Regarding antibiotic therapy, most facilities offered completion of intravenous antibiotic course inpatient or at a skilled nursing facility (94% and 75%, respectively). Other treatment options less commonly offered by facilities included: transition to oral antibiotics (56%), use of long-acting lipoglycopeptides (50%), and outpatient parenteral antibiotic therapy (25%). Of the 16 facilities that completed the survey, only 7 performed cardiac surgery and 6 performed catheter-based interventions. Conclusions: Although most facilities surveyed offered completion of antibiotic therapy either as inpatient or at a skill nursing facility, they were less likely to offer alternative options such as home infusion antibiotics, long-acting antibiotics, or oral antibiotic treatment for endocarditis. Most facilities screened for substance abuse on admission, but few provided addiction services. There may be an opportunity to enhance care for PWID through alternative antibiotic therapies and addiction services.
- 27 March 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (4) , ofaf150
Open AccessTrends in the Management of Infective Endocarditis for Patients Who Inject Drugs: A Survey of Healthcare Facilities in Tennessee
Background: The current endocarditis management strategies among Tennessee healthcare facilities for people who inject drugs (PWID) were evaluated. Methods: This was a survey-based study of healthcare facilities that treat infective endocarditis in PWID within Tennessee. The primary outcome of the study was to describe current practice among facilities regarding the treatment of endocarditis in PWID, including approaches to addiction management, antimicrobial therapy, and cardiac surgery. Results: There were 17 facilities that responded to the survey but only 16 facilities completed the entire survey. Although 15 facilities (88%) responded that they evaluate patients for substance use disorders on admission, only 4 (24%) of those facilities offered addiction consultation service. Regarding antibiotic therapy, most facilities offered completion of intravenous antibiotic course inpatient or at a skilled nursing facility (94% and 75%, respectively). Other treatment options less commonly offered by facilities included: transition to oral antibiotics (56%), use of long-acting lipoglycopeptides (50%), and outpatient parenteral antibiotic therapy (25%). Of the 16 facilities that completed the survey, only 7 performed cardiac surgery and 6 performed catheter-based interventions. Conclusions: Although most facilities surveyed offered completion of antibiotic therapy either as inpatient or at a skill nursing facility, they were less likely to offer alternative options such as home infusion antibiotics, long-acting antibiotics, or oral antibiotic treatment for endocarditis. Most facilities screened for substance abuse on admission, but few provided addiction services. There may be an opportunity to enhance care for PWID through alternative antibiotic therapies and addiction services.